# NGEN-Enzy LP — Form D/A

NGEN-Enzy LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-09-03. $21.6M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2024-09-03
- Form: D/A
- Accession: 0002005822-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $21.6M
- Investors: 7
- Date of first sale: 2024-01-04
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-500867

## Issuer

- Name: NGEN-Enzy LP
- CIK: 0002005822
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O NGEN ENZYMEDICA LLC, NEW YORK, NY, 10021
- Phone: 212.450.9704

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| N/A NGEN Enzymedica LLC | Director | New York, NY |
| Peter Grubstein | Executive Officer | New York, NY |
| Shay Murphy | Executive Officer | New York, NY |
| Rosemary Ripley | Executive Officer | New York, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-12-27](https://search.stillhousedata.com/formd/0001012975-23-000525) | D | — | — |

## More

- [CIK 2005822 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2005822&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002005822-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.